EODData

MEMBERSHIP REGISTER LOG IN

OTCBB, PARD: Poniard Pharmaceuticals Inc

09 Oct 2025
LAST:

0.0001

CHANGE:
 0.00		OPEN:
0.0001		HIGH:
0.0001		ASK:
0.0000		VOLUME:
1.8K
CHG(%):
0.00		PREV:
0.0001		LOW:
0.0001		BID:
0.0000		 

CHART

RECENT END OF DAY PRICES

DateOpenHighLowCloseVolume
09 Oct 250.00010.00010.00010.00011.8K

COMPANY PROFILE

Name:Poniard Pharmaceuticals Inc
About:Poniard Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of cancer therapeutics. Its lead platform product candidate includes Picoplatin, a platinum-based cancer therapy to treat multiple cancer indications, including small cell lung, colorectal, prostate, and ovarian cancers. The company has conducted a pivotal Phase III SPEAR trial of Picoplatin in the second-line treatment of patients with small cell lung cancer; Phase II trials evaluating picoplatin as a first-line treatment of metastatic colorectal cancer and castration-resistant prostate cancer; and a Phase I study evaluating an oral formulation of picoplatin in solid tumors. The company was formerly known as NeoRx Corporation and changed its name to Poniard Pharmaceuticals, Inc. in September 2006. Poniard Pharmaceuticals, Inc. was founded in 1984 and is based in Seattle, Washington.
Sector:Healthcare
Industry:Biotechnology
Address:300 Elliott Avenue West, Seattle, WA, United States, 98119
Website:https://www.poniard.com/
CUSIP:732449202
CIK:0000755806
ISIN:US7324494001
FIGI:BBG000C50H51

API SERVICE  NEW

Have you tried our new API Service yet?

For more information, visit our API page.

You can get your ApiKey over HERE.

If you're ready to get going, then jump over to:
https://api.eoddata.com

SYMBOL HISTORY

   Add to Watchlist

DOWNLOAD DATA

Download stock quote history quickly and easily in a variety of formats to suit your needs.

  Download

TECHNICAL INDICATORS

MA5:0.000.0%
Week High:0.000.0%
Week Low:0.000.0%